MoneyWorks4Me

The company witnessed a 9.27% growth in the revenue at Rs. 16326.70 millions for the quarter ended September 2024 as compared to Rs. 14941.40 millions during the year-ago period.A slim rise of 14.59% was recorded in the Net profit for the quarter ended September 2024 to Rs. 3586.10  millions  From Rs. 3129.40 millions.Operating Profit saw a handsome growth to 4994.40 millions from 4363.90 millions in the quarter ended September 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 16326.70 14941.40 9.27 31902.80 29731.40 7.30 58489.10 53487.30 9.35
Other Income 604.80 555.10 8.95 1278.10 1115.10 14.62 2482.70 1541.50 61.06
PBIDT 4994.40 4363.90 14.45 9577.80 8473.90 13.03 17013.70 13597.80 25.12
Interest 25.00 31.30 -20.13 52.50 64.70 -18.86 124.50 159.90 -22.14
PBDT 4969.40 4332.60 14.70 9525.30 8409.20 13.27 16889.20 13437.90 25.68
Depreciation 175.10 178.40 -1.85 358.80 350.10 2.49 711.70 699.70 1.72
PBT 4794.30 4154.20 15.41 9166.50 8059.10 13.74 16177.50 12738.20 27.00
TAX 1208.20 1024.80 17.90 2300.30 2027.30 13.47 4165.30 3244.10 28.40
Deferred Tax -2.10 -18.00 -88.33 -23.70 -35.60 -33.43 10.70 -11.90 -189.92
PAT 3586.10 3129.40 14.59 6866.20 6031.80 13.83 12012.20 9494.10 26.52
Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00
PBIDTM(%) 30.59 29.21 4.74 30.02 28.50 5.33 29.09 25.42 14.42
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..